GF CSI HK Innovative Drugs Industry ETF(QDII)
5131201.1550.70% ( +0.008 )
About
- Name
- GF CSI HK Innovative Drugs Industry ETF(QDII)
- Index tracked
- CSI HK Brand Name Drug Id PR HKD
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 1.1572 (07/29/2026)
- Issued units
- 22.61B (06/30/2026)
- Listing date
- Jul 1, 2022
- Sponsor
- GF Fund Mgmt Co.,Ltd
- Custodian
- Bank of Communications
ETF Documents
Last updatedType
07/20/2026Quarterly Report
07/06/2026Prospectus
09/01/2025Semi Annual Report
03/30/2026Annual Report